Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR0284)
Drug Name
Cefalexin
Synonyms
Carnosporin; Cefablan; Cefadin; Cefadina; Cefaleksin; Cefalexin; Cefalexina; Cefalexine; Cefalexinum; Cefalin; Cefaloto; Cefaseptin; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalexin monohydrate; Cephalexine; Cephalexinum; Cephanasten; Ceporex; Ceporexin; Ceporexine; Cophalexin; Factagard; Kefalospes; Keflet; Keflex; Alcephin; Kefolan; Kidolex; Lenocef; Lexibiotico; Medoxine; Novolexin; Ortisporina; Palitrex; Sartosona; Sencephalin; Servispor; Sinthecillin; Sporicef; Tepaxin; Tokiolexin; Zozarine; cephalexin; 15686-71-2; Pectril
Indication Acute otitis media [ICD11: AB00] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 347.4 Topological Polar Surface Area 138
Heavy Atom Count 24 Rotatable Bond Count 4
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6
Cross-matching ID
PubChem CID
27447
PubChem SID
9112 ; 594576 ; 625390 ; 7847329 ; 7978893 ; 8169783 ; 11466386 ; 11467506 ; 11486112 ; 14778344 ; 14876054 ; 26719711 ; 29215501 ; 34669971 ; 46386774 ; 46506749 ; 47291384 ; 47515590 ; 47811031 ; 48259499 ; 48415740 ; 48631157 ; 49698453 ; 50050891 ; 50064641 ; 50109863 ; 56314309 ; 57310443 ; 79988419 ; 85788571 ; 87246423 ; 92308234 ; 103682056 ; 104029668 ; 104300019 ; 108667050 ; 121277919 ; 124658838 ; 124766007 ; 126672951 ; 129874110 ; 134221931 ; 134337733 ; 134991978 ; 135692166 ; 136367997 ; 137001569 ; 137240151 ; 139157607 ; 144089066
ChEBI ID
CHEBI:3534
CAS Number
15686-71-2
TTD Drug ID
D0Z5EM
Formula
C16H17N3O4S
Canonical SMILES
CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
InChI
1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
InChIKey
ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 2D6 (CYP2D6) DME0009 Homo sapiens
CP2D6_HUMAN
1.14.14.1
[2]
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[3]
N-acylhomoserine lactone acylase (lacA) DME1021 Acidovorax ebreus
A0A0A1VBK6_9BURK
3.5.1.97
[4]
References
1 Cefalexin was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 Population pharmacokinetic analysis of mirtazapine. Eur J Clin Pharmacol. 2004 Sep;60(7):473-80.
3 Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharm Res. 1999 Sep;16(9):1352-9.
4 A novel quorum-quenching N-acylhomoserine lactone acylase from Acidovorax sp. strain MR-S7 mediates antibiotic resistance. Appl Environ Microbiol. 2017 Jun 16;83(13). pii: e00080-17.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.